CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia (vol 66, pg 15, 2018)
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Hubei, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Huang Jinjin,Wang Zhiqiong,Huang Lifang,et al.CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia (vol 66, pg 15, 2018)[J].LEUKEMIA RESEARCH.2018,68:120-120.doi:10.1016/j.leukres.2018.04.005.
APA：
Huang, Jinjin,Wang, Zhiqiong,Huang, Lifang&Zheng, Miao.(2018).CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia (vol 66, pg 15, 2018).LEUKEMIA RESEARCH,68,
MLA：
Huang, Jinjin,et al."CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia (vol 66, pg 15, 2018)".LEUKEMIA RESEARCH 68.(2018):120-120
